Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 clinical trial evaluating induction Modified TPF followed by concurrent chemoradiotherapy for locally advanced head and neck squam…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients [Phase 2]
Phase 2 trial evaluating the efficacy and safety of transdermal buprenorphine for radiation-induced mucositis pain in patients with head and…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET [Phase 1, Phase 2]
This is a clinical trial update for Phase 1/Phase 2 evaluation of molecular imaging of the DNA damage response using the [18F]-labeled Olapa…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of tislelizumab and SBRT for head and neck squamous cell carcinoma, currently recruiting…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
This clinical trial update examines cisplatin-induced cochlear and vestibular damage, including hearing loss, in patients with head and neck…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: A Phase 1b Study of WU-NK-101 in Combination With Cetuximab [Phase 1]
A Phase 1b trial evaluates WU-NK-101 in combination with cetuximab for metastatic colorectal cancer and head and neck squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma [EARLY_Phase 1]
An early-phase pilot study evaluating glutamine PET imaging for head and neck squamous cell carcinoma, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of CMP-001 in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma has been termin…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy [NA]
Ongoing clinical trial evaluating radiobiological effects related to skin toxicities in head and neck cancer patients treated with pencil-be…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC [Phase 2]
Ongoing Phase 2 clinical trial evaluating the combination of Ibrutinib with Nivolumab or Cetuximab for recurrent/metastatic head and neck ca…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients [Phase 2]
Phase 2 clinical trial evaluating MIT-001 to prevent oral mucositis caused by concurrent chemoradiation in patients with head and neck squam…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: PET/CT Follow up for Head and Neck Squamous Cell Carcinoma [NA]
A clinical trial update indicates that a study evaluating PET/CT follow-up for head and neck squamous cell carcinoma is currently recruiting…
-
CLINICAL_TRIALS withdrawal · 2025-04-04Clinical Trial Update: Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC [Phase 2]
Phase 2 trial of vorinostat with chemoradiation for locally advanced head and neck squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Needs and Preferences of Patients With Head-neck Cutaneous SCC
A clinical trial investigating the needs and preferences of patients with cutaneous squamous cell carcinoma of the head and neck; the study …
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1]
Phase 1 clinical trial update evaluating the combination of avelumab, cetuximab, and palbociclib in recurrent or metastatic head and neck sq…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TT-10 and TT-4 (Portage Biotech) exploring single-agent and combination therapy in advanced solid tumors, with rec…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
A clinical trial update describing molecular-based selection of patients with locally advanced head and neck squamous cell carcinoma using b…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors [Phase 1, Phase 2]
This clinical trial update describes evaluation of the PET tracer [18F]AlF-NOTA-PCP2 for PD-L1 detection across malignant tumors, including …
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TU2218 in combination with pembrolizumab (Keytruda) in patients with advanced solid tumors is currentl…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC [Phase 2]
A Phase 2 single-center trial is evaluating AHCC in combination with standard-of-care therapy for HPV-positive head and neck squamous cell c…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients [Phase 2]
Phase 2 clinical trial update on Voyager V1 in combination with cemiplimab in cancer patients, with conditions including melanoma, head and …
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating AP203 in patients with locally advanced or metastatic solid tumors, including non-small cell …
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2 [NA]
This ClinicalTrials.gov update describes a study investigating the role of the microbiome as biomarkers in locoregionally-advanced oropharyn…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC [NA]
The study investigates peritumoral microbubbles and contrast-enhanced ultrasound for sentinel lymph node detection and biopsy in head and ne…